ASTEC LIFESCIENCES
|
ASTEC LIFESCIENCES Last 5 Year Financial Ratios History
[Consolidated]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | -23.93 | 13.04 | 45.85 | 33.21 | 24.28 |
| CEPS(Rs) | -5.42 | 30.22 | 63.39 | 46.32 | 36.13 |
| DPS(Rs) | - | 1.50 | 1.50 | 1.50 | 1.50 |
| Book NAV/Share(Rs) | 188.13 | 213.72 | 202.17 | 157.63 | 125.66 |
| Tax Rate(%) | 24.06 | 26.76 | 25.79 | 26.95 | 22.53 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | -1.29 | 12.08 | 22.66 | 19.94 | 16.21 |
| EBIT Margin(%) | -7.95 | 8.82 | 19.15 | 16.79 | 14.07 |
| Pre Tax Margin(%) | -13.44 | 5.54 | 17.82 | 15.94 | 11.67 |
| PAT Margin (%) | -10.21 | 4.05 | 13.22 | 11.64 | 9.04 |
| Cash Profit Margin (%) | -2.32 | 9.39 | 18.27 | 16.24 | 13.45 |
| Performance Ratios | |||||
| ROA(%) | -4.80 | 2.69 | 11.21 | 10.42 | 9.20 |
| ROE(%) | -11.90 | 6.28 | 25.50 | 23.46 | 21.24 |
| ROCE(%) | -4.50 | 7.75 | 22.21 | 22.29 | 20.44 |
| Asset Turnover(x) | 0.47 | 0.66 | 0.85 | 0.89 | 1.02 |
| Sales/Fixed Asset(x) | 0.85 | 1.31 | 1.72 | 1.91 | 2.14 |
| Working Capital/Sales(x) | 344.64 | -23.08 | 27.10 | 68.53 | 39.26 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 1.18 | 0.76 | 0.58 | 0.52 | 0.47 |
| Receivable days | 128.71 | 123.89 | 123.70 | 113.66 | 98.14 |
| Inventory Days | 194.99 | 139.29 | 78.67 | 74.22 | 74.31 |
| Payable days | 152.31 | 166.93 | 150.04 | 176.37 | 143.21 |
| Valuation Parameters | |||||
| PER(x) | - | 106.02 | 38.22 | 30.12 | 16.47 |
| PCE(x) | -195.78 | 45.75 | 27.64 | 21.60 | 11.07 |
| Price/Book(x) | 5.65 | 6.47 | 8.67 | 6.35 | 3.18 |
| Yield(%) | - | 0.11 | 0.09 | 0.15 | 0.38 |
| EV/Net Sales(x) | 5.62 | 4.85 | 5.49 | 3.87 | 1.68 |
| EV/Core EBITDA(x) | -9,579.67 | 34.14 | 22.56 | 17.95 | 9.06 |
| EV/EBIT(x) | -70.48 | 54.78 | 28.51 | 22.86 | 11.90 |
| EV/CE(x) | 2.98 | 4.01 | 4.01 | 3.17 | 2.55 |
| M Cap / Sales | 4.55 | 4.31 | 5.08 | 3.53 | 1.50 |
| Growth Ratio | |||||
| Net Sales Growth(%) | -27.06 | -7.15 | 21.93 | 6.17 | 21.28 |
| Core EBITDA Growth(%) | -100.30 | -45.72 | 37.72 | 23.03 | 10.82 |
| EBIT Growth(%) | -165.61 | -57.24 | 38.76 | 26.88 | 8.30 |
| PAT Growth(%) | -283.21 | -71.53 | 38.13 | 36.91 | 32.89 |
| EPS Growth(%) | -283.54 | -71.56 | 38.07 | 36.78 | 32.84 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 1.34 | 0.81 | 0.71 | 0.61 | 0.40 |
| Current Ratio(x) | 1.00 | 0.95 | 1.05 | 1.03 | 1.04 |
| Quick Ratio(x) | 0.51 | 0.39 | 0.67 | 0.70 | 0.66 |
| Interest Cover(x) | -1.45 | 2.69 | 14.37 | 19.75 | 5.87 |
| Total Debt/Mcap(x) | 0.24 | 0.13 | 0.08 | 0.10 | 0.13 |
Compare Financial Ratios of peers of ASTEC LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ASTEC LIFESCIENCES | ₹2,062.2 Cr | -0.7% | -2.4% | -17.1% | Stock Analytics | |
| PI INDUSTRIES | ₹62,774.1 Cr | -7% | -6% | 12.5% | Stock Analytics | |
| UPL | ₹41,696.2 Cr | 8% | 1.9% | -2.4% | Stock Analytics | |
| BAYER CROPSCIENCE | ₹26,010.5 Cr | -4.8% | -13.1% | 3.7% | Stock Analytics | |
| SUMITOMO CHEMICAL INDIA | ₹25,419.0 Cr | -0.2% | -3.5% | 32.2% | Stock Analytics | |
| BASF INDIA | ₹25,296.3 Cr | -7.6% | -24.2% | 103.5% | Stock Analytics | |
ASTEC LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ASTEC LIFESCIENCES | -0.7% |
-2.4% |
-17.1% |
| SENSEX | -1.9% |
-5% |
17.5% |
You may also like the below Video Courses
